“Julie has been at the center of some of the most important OTC switches of the past several decades, helping shape the science that gives regulators confidence and consumers greater access to self-care products.”
"CHPA is disappointed that AB 2030, as signed into law, does not strike a better balance between our shared goal of protecting minors and preserving access to safe, beneficial products for adults who use them responsibly."
CHPA, AHPA and CRN say the legislation would clarify FDA drug preclusion rules and provide greater regulatory certainty for dietary supplements.
Winners across six self-care marketing categories will be announced November 11 at the Health In Hand Foundation Gala in Philadelphia.
Scott Melville will conclude a 16-year tenure during which CHPA expanded its reach across the broader self-care industry.
"We are pleased the Administration is moving quickly to appoint a permanent leader of the FDA. Stable, science-based leadership is essential to a smooth-functioning FDA.”
Both groups warning that the government's approach risks confusing consumers and disrupting product availability without a clear scientific basis.
CHPA said self-care interventions save an estimated 1.3 billion hours and $31.8 billion in healthcare-related costs annually across North America.
New law raises the annual purchase limit for pseudoephedrine products while maintaining safeguards against misuse.
“CHPA is fortunate to have exceptional industry leaders volunteer their time to help direct the association’s priorities and oversee its governance,” said Scott Melville, President and CEO of CHPA.
The trade association said that the pace of leadership turnover at the FDA over the past year has created uncertainty among industry stakeholders.
The new law modernizes access by enabling online sales of PSE-containing medicines and removing outdated barriers to purchase, while continuing to rely on Tennessee’s real-time electronic tracking system to prevent misuse.
“OTC medicines are a cornerstone of self-care, enabling millions of Americans to safely and effectively manage common conditions without a prescription,” said CHPA's David Spangler.
The awards spotlight strategic innovation and execution across key categories, including digital marketing, multicultural and inclusive campaigns, shopper marketing, and product launches.
“CHPA is privileged to be guided by outstanding industry leaders who volunteer their time and expertise to serve on our board of directors,” said CHPA President and CEO Scott Melville.
Sawaya has been deeply involved with CHPA for more than two decades, serving as a trusted advisor to member companies and contributing to broader industry dialogue around consumer healthcare.
